Analytics and brochures
Pepeliaev Group advises that on 3 March 2014 the Russian Ministry of Justice registered Order No. 1607 of the Russian Ministry of Industry and Trade dated 4 October 2013 "On approving the Administrative Regulation for the Russian Ministry of Industry and Trade to perform the state function of licensing control over the manufacturing of medicines for medical use" (the "Regulation").
At the federal level, industry-specific agreements have been entered into which set out additional obligations and automatically apply to companies working in the areas of road facilities, motor, rail and above-ground city passenger transport. To refuse to join the agreements, a well-grounded refusal should be submitted to the Russian Ministry of Labour and Social Protection by 25 March 2014.
For the attention of: heads of healthcare organizations which conduct clinical trials of medical products as well as R&D and registration units of producers/distributors of medical products.
For the attention of: managers of companies in Eastern Siberia and companies of the federal and interregional levels operating in Eastern Siberia.
Pepeliaev Group advises of the progress of measures being implemented to develop Eastern Siberia as communicated by the President of Russia in his Address to the Federal Assembly.
Pepeliaev Group advises that preparations have started for staging the World Winter Universiade 2019 in Krasnoyarsk and explains the issues that companies face when major international sport events are staged in Russia.
Pepeliaev Group advises that the new Regulation No. 408-P of the Central Bank of Russia (“CBR”) comes into force on January 31, 2014. This establishes a new procedure for the CBR to approve candidates for management positions at banks, as well as to attest to the business reputation of Board members and shareholders holding more that 10% of the shares in the bank in question.